Search results for "guide"

showing 10 items of 1478 documents

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients

2017

International audience; The advent of safe and highly effective direct-acting antiviral agents (DAAs) has had huge implications for the hepatitis C virus (HCV) transplant field, and changed our management of both patients on the waiting list and those with HCV graft re-infection after liver transplantation (LT). When treating HCV infection before LT, HCV re-infection of the graft can be prevented in nearly all patients. In addition, some candidates show a remarkable clinical improvement and may be delisted. Alternatively, HCV infection can be treated post-LT either soon after the transplant, taking advantage of the removal of the infected native liver, or at the time of disease recurrence, …

Hepatitis C chronicDrugmedicine.medical_specialtyConsensusAntiviral agentmedicine.medical_treatmentHepatitis C virusmedia_common.quotation_subjectWaiting listDiseaseGuidelineLiver transplantationGuidelinesmedicine.disease_cause03 medical and health sciences0302 clinical medicineMED/12 - GASTROENTEROLOGIAMedicineHumansDrug InteractionsIntensive care medicinemedia_commonLiver transplant candidateLiver transplantationHepatologybusiness.industryWaiting listsLiver failure[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyRecurrent hepatitis CDirect Antiviral AgentHepatitis C3. Good healthSurgerychronicAntiviral agentsWaiting list030220 oncology & carcinogenesisInterferon030211 gastroenterology & hepatologyLiver transplant recipientInterferonsbusinessComplication
researchProduct

Imaging-guided interventions modulating portal venous flow: Evidence and controversies

2021

Portal hypertension is defined by an increase in the portosystemic venous gradient. In most cases, increased resistance to portal blood flow is the initial cause of elevated portal pressure. More than 90% of cases of portal hypertension are estimated to be due to advanced chronic liver disease or cirrhosis. Transjugular intrahepatic portosystemic shunts, a non-pharmacological treatment for portal hypertension, involve the placement of a stent between the portal vein and the hepatic vein or inferior vena cava which helps bypass hepatic resistance. Portal hypertension may also be a result of extrahepatic portal vein thrombosis or compression. In these cases, percutaneous portal vein recanalis…

HepatologyGastroenterologyInternal MedicineImmunology and AllergyALPPS associating liver partition and portal vein ligation for staged hepatectomy transjugular intrahepatic portosystemic shunt BSG British Society of Gastroenterology EASL European Association for the Study of the Liver FLR future liver remnant HE hepatic encephalopathy NCBA N-butyl cyanoacrylate PH portal hypertension PVE portal vein embolisation PVR portal vein recanalisation TIPS transjugular intrahepatic portosystemic shunt Portal vein interventions TACE trans-arterial chemoembolization portal vein recanalization RCT randomised controlled trial portal vein embolization portal hypertension image guidedJHEP Reports
researchProduct

Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S01688278173…

2018

It has come to our attention that the PITER framework investigator, Alessandro Federico, was incorrectly listed as F. Alessandro in the original manuscript. Please note that the correct name of this author is Alessandro Federico (2nd University of Naples). The correct list of PITER investigators is in the footnote below.

HepatologyHepatitis B; EASL guidelines; Treatment; Interferon; Entecavir; Tenofovir; TAF; HBsAg; Hepatocellular carcinoma; HBV DNA; HBV reactivation; Mother to child transmissionHepatocellular carcinomaHBV reactivationEASL guidelinesHepatitis BEntecavirTreatmentHBsAgTAFHBV DNAMother to child transmissionInterferonTenofovirEASL guideline
researchProduct

Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines

2018

The American College of Cardiology (ACC) and the American Heart Association (AHA) have recently published their guidelines for the prevention, detection, evaluation, and management of hypertension in adults. The most controversial issue is the classification threshold at 130/80 mmHg, which will allow a large number of patients to be diagnosed as hypertensive who were previously considered normotensive. Blood pressure (BP) is considered normal (<120 mmHg systolic and <80 mmHg diastolic), elevated (120-129 and <80 mmHg), stage 1 (130-139 or 80-89 mmHg), and stage 2 (≥140 or ≥90 mmHg). Out-of-office BP measurements are recommended to confirm the diagnosis of hypertension and for titra…

Hipotensió arterialCorazónMedicinaMalalties cardiovascularsEnfermedad cardiovascularGuidelines030204 cardiovascular system & hematologyCardiovascular diseaseCardiovascular riskPressió sanguíniaPresión sanguínea03 medical and health sciencesCardiovascular diseases0302 clinical medicineHypertensionHipertensiónBlood pressureInternal Medicine030212 general & internal medicineHypotensionCardiology and Cardiovascular MedicineSistema cardiovascular
researchProduct

Helical Tomotherapy® is a safe and feasible technique for total scalp irradiation

2017

Angiosarcoma of the scalp is a rare aggressive tumor that affects elderly patients. Chemoradiation is the treatment of choice for multicentric and extensive disease. The shape of the scalp represents a dosimetric challenge in terms of achieving a homogeneous concave dose distribution with coverage of the entire target volume and an acceptable organs-at-risk sparing. We report a case of an 81-year-old man with a multifocal angiosarcoma of the scalp treated with Helical TomoTherapy® (Accuray Inc., Sunnyvale, CA, USA) intensity modulated radiotherapy. This technique allows precise and daily verifiable coverage of the target keeping the dose to the organs at risk within the constraints.

Histologymedicine.medical_treatmentPlanning target volumeCase ReportDose distributionTomotherapylcsh:RC254-282Tomotherapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineTomotherapy IGRT IMRT Scalp irradiation AngiosarcomamedicineAngiosarcomaAngiosarcomaIMRTIGRTImage-guided radiation therapyExtensive Diseaseintegumentary systembusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.anatomical_structureOncologyHomogeneous030220 oncology & carcinogenesisScalpScalp irradiationNuclear medicinebusinessRare Tumors
researchProduct

Las publicaciones divulgativas como vehículo de difusión del patrimonio arqueológico: bibliografía de guías arqueológicas en España 1975-2005

2008

Se realiza una aproximación a las publicaciones de carácter divulgativo como medio para difundir y dar a conocer el patrimonio arqueológico. Para ello, se identifica y caracteriza un determinado género de publicaciones divulgativas: las guías arqueológicas. Se presenta una bibliografía de la literatura de este género publicada a lo largo de las tres últimas décadas en España, analizando la evolución diacrónica del número de publicaciones, la cobertura geográfica, las entidades editoras, la estructura y los contenidos recogidos en este tipo de obras. We analyse Popular Science Archaeological Books as a way of spreading the popularization of archaeological heritage. In that sense, we identifi…

HistoryPatrimonio arqueológico; Divulgación científica; Publicaciones divulgativas; Guías arqueológicasArchaeolog-ical guidesPublicaciones divulgativaslcsh:Recreation. LeisureUNESCO::LINGÜÍSTICA::Lingüística aplicada::Documentaciónlcsh:GV1-1860Divulgación científicaArchaeological guides:LINGÜÍSTICA::Lingüística aplicada::Documentación [UNESCO]Popularization of scienceBibliographyArchaeological heritageArchaeological heritageGuías arqueológicasPopular Science Archaeological BooksPopular scienceHumanitiesPatrimonio arqueológicoPASOS Revista de Turismo y Patrimonio Cultural
researchProduct

Bone marrow biopsy in Hodgkin's lymphoma.

2004

In the study of patients with Hodgkin's lymphoma (HL) the evaluation of bone marrow biopsy (BMB) can be difficult. In this review we analyze the main diagnostic features and the clinical risk factors of BM involvement. Although the role of BMB is criticized by some authors, its value is irreplaceable in the staging of HL and in the diagnosis of primary medullary HL. The Ann Arbor staging committee criteria should be revised and updated in the light of the current immunohistochemical studies that give a fundamental help in the diagnostic process. A single BMB should be adequate for diagnosis in most instances. In cases of suspicious involvement a controlateral BMB could be performed.

Hodgkin's lymphoma.Diagnosis DifferentialPractice Guidelines as TopicHumansBone marrowbiopsyBone Marrow ExaminationHodgkin DiseaseImmunophenotypingEuropean journal of haematology
researchProduct

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper fr…

2014

Item does not contain fulltext AIMS: Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease (ACVD). Given recent insights into the heterogeneity of genetic defects and clinical phenotype of HoFH, and the availability of new therapeutic options, this Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) critically reviewed available data with the aim of providing clinical guidance for the recognition and management of HoFH. METHODS AND RESULTS: Early diagn…

Homozygous Familial HypercholesterolemiaSettore MED/09 - Medicina InternaVascular damage Radboud Institute for Health Sciences [Radboudumc 16]MipomersenLipoprotein apheresisGene FrequencyDiagnosisconsensuMedicineChildPhenotypic heterogeneityCiències de la salutAnticholesteremic AgentsHomozygoteCiencias de la saludPedigree3. Good healthEuropePhenotypeCardiovascular DiseasesPractice Guidelines as TopicBlood Component Removallipids (amino acids peptides and proteins)HipercolesterolèmiaHIPERCOLESTEROLEMIA (DIAGNÓSTICO)Cardiology and Cardiovascular MedicineLipoprotein apheresismedicine.medical_specialtyConsensusClinical UpdateEvinacumabReviewsguide line1102 Cardiovascular Medicine And Haematology1016-5169Diagnosis DifferentialHyperlipoproteinemia Type IIGenetic HeterogeneityArcus SenilisHomozygous familial hypercholesterolaemiaGeneticsXanthomatosisHumansGynecologybusiness.industryStatinsHealth sciencesCholesterol LDLAtherosclerosisEzetimibeLomitapideLiver TransplantationEarly DiagnosisCardiovascular System & HematologyHomozygous familial hypercholesterolaemia; consensus; guide lineMutationEuropean atherosclerosis societybusinessAterosclerosiEuropean Heart Journal
researchProduct

Addressing and control of optical nanosources by integrated or fibered plasmonics

2015

Surface plasmon polariton (SPP) can confine light on subwavelength dimensions. Since they are not diffraction limited, they are of great interest for addressing and controlling optical nanosources. For example, a metal nanowire defines 1D plasmonic waveguide with a great potential for either addressing or coupling quantum emitters. Therefore, SPP opens great opportunities for integrated optical applications. However, SPP suffer from ohmic losses that jeopardize the applications of plasmonic components. In this context, we study the possibilities provided by an hybrid plasmonic-photonicstructure to couple efficiently an emitter to a fiber mode. Such a structure paves the way for fibered sing…

Hybrid plasmonic waveguideGuide plasmonique hybrideCoupled lossy mode theoryThéorie des modes couplés en présence de pertes[PHYS.PHYS] Physics [physics]/Physics [physics]Facteur de PurcellPurcell factor
researchProduct

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.

2009

Udgivelsesdato: 2009-Oct This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 64:1427-1443] is the result of a consensus reached during a panel discussion at the 3rd International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Allergy Organ…

Hypersensitivity Immediatemedicine.medical_specialtyClinical immunologyUrticariaImmunologyimmune system diseasesparasitic diseasesmedicinePrevalenceImmunology and AllergyNetwork of excellencemedia_common.cataloged_instanceHumansPhysical urticariaEuropean unionskin and connective tissue diseasesChildmedia_commonPanel discussionAcute urticariabusiness.industryInfantGuidelineAllergensmedicine.diseaseDermatologyFamily medicineChild PreschoolChronic idiopathic urticariabusiness
researchProduct